🔎 Trials Near Me

Home › Alzheimer's Disease › NCT05010603

Late Onset Alzheimer's Disease

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 55 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Established diagnosis of definite or probable AD or have a diagnosis of a related neurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy Body Dementia (LBD) (will also recruit sporadic FTD and LBD) cases.
* a living sibling with probable or possible AD;
* a third living relative affected with AD (onset age 50 or older) or unaffected (60 or older);
* participants in the proband's generation with an identified companion serving as an informant;
* participants who have capacity to consent or participants lacking capacity to consent with a surrogate/proxy in place to provide consent.

Exclusion Criteria:

* failure to identify an appropriate informant;
* uncertainty of the clinical diagnosis of Alzheimer's disease or other related disorder;
* discovery of additional diagnosis that could account for the clinical manifestations;
* unwillingness to participate;
* failure to identify a living sibling with AD or other related disorder (except in the cases of sporadic FTD and sporadic LBD);
* participants lacking the capacity to consent who do not have a surrogate or proxy or next of kin to provide consent.

About the study

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

What is being tested

Sponsor: Columbia University · Participants: 10,000 · Started: Nov 15, 2016

Contact the study team

Official record on ClinicalTrials.gov — NCT05010603

Locations in the U.S.

District of ColumbiaUniversity of Washington, Washington D.C.
FloridaUniversity of Miami, Miami
IllinoisRush University, Aurora
IndianaIndiana University, Bloomington
NCRAD at Indiana University, Indianapolis
MinnesotaMayo Clinic, Rochester
MissouriJoanne Norton, St Louis
New YorkColumbia University Irving Medical Center, New York
North CarolinaNorth Carolina State University, Raleigh
PennsylvaniaUniversity of Pittsburgh, Pittsburgh
TexasUniversity of Texas Southwestern, Dallas
WashingtonUniversity of Washington, Seattle

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.